Proxy Materials

SELLAS Life Sciences Group, Inc. Filed 2016-07-08 Acc 0001390478-16-000120

Documents 1

2017-04-20 DEFA14A Proxy Materials
2016-07-08 4 Chief Medical Officer acquired 8,503 shares (other)
2016-07-08 DEFA14A Proxy Materials
2016-07-08 424B5 Prospectus
2016-07-08 8-K Material agreement · Results of operations · Unregistered share sale · Other events
2016-07-06 4 President & CEO acquired 8,503 shares (other)
2016-06-09 DEFA14A Proxy Materials

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading gale-20160708xformdefaaddi.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…